For the “ferroptosis” pathway, expression of seven genes was higher (FTH1, FTL, ASCL6, ACSL4, MAP1LC3A, TFRC, and GSS) and expression of three genes was lower (SLC40A1, CP, and MAP1LC3C) in NASH. Here, FTL is linked to metabolic dysfunction-associated steatohepatitis.